ID-CRU: In The News
COVID-19 Vaccine Trials at SLU and WashU Recruit St. Louis Area Residents“Rachel Presti, MD, PHD is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for the COVID-19 vaccine trials. Presti and Frey are coordinating so the two institutions can lead different vaccine trials.” |
|
 Researchers at Washington University School of Medicine in St. Louis and the Saint Louis University Center for Vaccine Development have joined the effort to find a COVID-19 vaccine that can prevent the illness. Researchers at the universities expect to enroll about 3,000 participants in several COVID-19 vaccine trials, with each school participating in different trials. (Photo: Getty Images) |
Rachel Presti, MD, PhD leads Washington University effort to conduct COVID-19 vaccine trials in collaboration with Saint Louis University |
Rachel Presti, MD, PhD, associate professor and investigator at the IDCRU/ACTU for HPTN 083 says study results are a game changer for HIV preventionHPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV |
 |
|
|
In two and a half weeks Jane O’Halloran, MD and Phil Mudd, MD create COVID-19 specimen bank |
Rachel Presti, MD, PhD and the Infectious Diseases Clinical Research Team collaborate in $3.4 million effort to make a better flu vaccine |
 The flu vaccine’s protection against influenza only lasts a few months. Researchers at Washington University School of Medicine in St. Louis are studying why immunity elicited by the flu vaccine wanes so rapidly. Their goal is to make a better, longer-lasting flu vaccine. (Getty Images) |
|
|
Patients with COVID-19 donate specimens to advance research efforts |
Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment |
 |
 |
COVID-19 survivors needed to donate blood plasma |
